Spinraza Improves Lung Function in SMA Type 2 Child, Report Says

Spinraza Improves Lung Function in SMA Type 2 Child, Report Says

300941

Spinraza Improves Lung Function in SMA Type 2 Child, Report Says

Spinraza (nusinersen), a treatment for spinal muscular atrophy (SMA) that helps improve motor function, was found to also improve lung function in a 10-year-old girl with advanced SMA type 2, a case report says. The report, “Nusinersen improved respiratory function in spinal muscular atrophy type 2,” was published in the journal Pediatrics International. Most people with SMA carry a mutation in SMN1, a gene that contains the information needed to make a protein called survival…

You must be logged in to read/download the full post.